Your browser doesn't support javascript.
loading
Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.
Pogosova, Nana; Bosch, Jacqueline; Bhatt, Deepak L; Fox, Keith A A; Connolly, Stuart J; Alings, Marco; Verhamme, Peter; Muehlhofer, Eva; Shestakovska, Olga; Yusuf, Salim; Eikelboom, John W.
Affiliation
  • Pogosova N; National Medical Research Centre of Cardiology, Moscow, Russia (N.P.).
  • Bosch J; Population Health Research Institute, Hamilton, Ontario, Canada (J.P., S.J.C., O.S., S.Y., J.W.E.).
  • Bhatt DL; McMaster University, Hamilton, Ontario, Canada (J.P., S.J.C., S.Y., J.W.E.).
  • Fox KAA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, (D.L.B.).
  • Connolly SJ; Centre for Cardiovascular Science, University of Edinburgh, United Kingdom (K.A.A.F.).
  • Alings M; Population Health Research Institute, Hamilton, Ontario, Canada (J.P., S.J.C., O.S., S.Y., J.W.E.).
  • Verhamme P; McMaster University, Hamilton, Ontario, Canada (J.P., S.J.C., S.Y., J.W.E.).
  • Muehlhofer E; Hamilton Health Sciences Hamilton, Ontario, Canada (S.J.C., S.Y., J.W.E.).
  • Shestakovska O; Amphia Ziekenhuis & WCN, Utrecht, The Netherlands (M.A.).
  • Yusuf S; University Leuven, Belgium (P.V.).
  • Eikelboom JW; Bayer AG, Wuppertal, Germany (E.M.).
Circulation ; 145(25): 1875-1877, 2022 06 21.
Article in En | MEDLINE | ID: mdl-35728054

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atherosclerosis / Venous Thromboembolism / Peripheral Arterial Disease Limits: Humans Language: En Journal: Circulation Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atherosclerosis / Venous Thromboembolism / Peripheral Arterial Disease Limits: Humans Language: En Journal: Circulation Year: 2022 Document type: Article Country of publication: